Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

9 Oct 2025 07:00

RNS Number : 6214C
Polar Capital Holdings PLC
09 October 2025
 

9 October 2025 Polar Capital Holdings plc

AuM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides an update in respect of the three months to 30 September 2025.

 

Group AuM (unaudited)

 

Polar Capital reports that as at 30 September 2025 its AuM was £26.7bn compared to £23.2bn at the end of June 2025, an increase of 15% over the quarter. In the quarter, AuM increased by fund performance and market movements of £3.6bn, offset by net outflows of £58m.

 

AuM movement in three months to 30 September 2025

Open ended

Funds

(£m)

Investment

Trusts

(£m)

Segregated mandates

(£m)

Total

(£m)

AuM at 1 July 2025

 

17,259

 

5,457

448

23,164

Net flows

 

50

 

(74)

(34)

(58)

Market movement

and performance

 

2,596

 

911

87

3,594

Total AuM at

30 September 2025

 

19,905

 

6,294

501

26,700

 

AuM movement in six months to 30 September 2025

Open ended

Funds

(£m)

Investment

Trusts

(£m)

Segregated mandates

(£m)

Total

(£m)

AuM at 1 April 2025

15,994

 

4,846

569

21,409

Net flows

(386)

 

(117)

(187)

(690)

Corporate action1

 

-

 

(280)

-

(280)

Market movement

and performance

4,297

1,845

119

6,261

Total AuM at

30 September 2025

19,905

6,294

501

26,700

1 Return of capital to investors in June 2025 as the Polar Capital Global Financials Trust underwent a 100% tender offer following which 44% of issued capital was tendered.

 

 

Net performance fee profits (unaudited)

 

The table below sets out the position relating to net performance fee profits due to the Group (after the deduction of staff interests) as a product of accrued performance fees in funds managed by the Group three months before the strike point of such performance fee receipts. There is no certainty that the fees will be sustained over the next quarter, as performance fees can be volatile.

 

Performance fees

net of staff allocations (All figures in £m)

Six months to

30 Sep 24

12 months to

31 Mar 25

(year-end)

Six months to

30 Sep 25

Received

-

7.9

-

Accrued in underlying funds with year ends on or before the financial year end

0.7

n/a

15.0*

Total net performance fee profits

0.7

7.9

15.0*

\* The figures exclude £1.5m of net performance fee distributions (staff allocations) that are deferred into future periods for accounting purposes, and which should be deducted from the total performance fee profit figure for the purposes of calculating adjusted total earnings per share.

 

Iain Evans, Chief Executive, commented:

"I am pleased to report that assets under management rose by 15% over the quarter to a new all-time high of £26.7bn, up from £23.2bn at the end of June. This £3.5bn increase reflected £3.6bn of positive fund performance and market movements and net outflows of £58m. 

 

"Equity markets have delivered robust returns so far this year, with enthusiasm around artificial intelligence continuing to drive major indices. Our meaningful exposure to technology has enabled us to benefit from this favourable backdrop.

 

"It is encouraging that the pace of redemptions has slowed significantly, with total net outflows of only £58m compared with net outflows of £632m in the prior quarter. Demand for our funds was broad-based, particularly across our higher-growth strategies. Those in net inflow included the Artificial Intelligence, Global Technology, Asian Stars, Emerging Market Stars, Biotechnology, Japan Value, Financial Credit, Global Absolute Return, Smart Energy, and International Small Company funds, which together generated £350m of net inflows during the quarter.

 

"Our European and UK strategies remained out of favour, with combined net outflows of £175m. The open-ended Global Technology Fund recorded net inflows of £226m compared to net outflows of £162m in the last quarter, having delivered a return 18% ahead of its benchmark calendar year to date. Elsewhere, the closure of an Emerging Market managed account was largely offset by the establishment of a new Biotechnology managed account, which was funded with an initial £93m by a U.S. endowment.

 

"At the Polar Capital Technology Trust AGM on 10 September 2025, shareholders voted overwhelmingly in favour of the Company's continuation, with approximately 99% of votes cast supporting the resolution.

 

"As I begin my tenure as CEO, I am proud to lead a firm that continues to demonstrate resilience and a clear sense of purpose. With signs emerging of a more supportive environment for active managers, Polar Capital is in a strong position as a specialist boutique. While macroeconomic uncertainty and investor caution persist, our focus remains on delivering long-term results for our clients and shareholders. Supported by significant fund capacity, improving performance across our active strategies, and the dedication of our talented teams, I am confident Polar Capital is well positioned for the years ahead."

 

 

For further information please contact:

 

Polar Capital

Iain Evans (Chief Executive)Samir Ayub (Chief Financial Officer)

+44 (0)20 7227 2700

 

Deutsche Numis - Nomad and Joint Broker

Giles Rolls

Charles Farquhar

 

+44 (0)20 7260 1000

 

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Thomas Philpott

 

 

+44 (0)20 3597 8680

Camarco - PR

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

+44 (0)20 3757 4980

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEASEPESFSFFA
Date   Source Headline
18th Sep 202011:20 amRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
10th Sep 202012:26 pmRNSForm 8.3 - HASTINGS GROUP
6th Aug 20203:31 pmRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
3rd Aug 20207:00 amRNSBlock listing Interim Review
3rd Aug 20207:00 amRNSTotal Voting Rights
31st Jul 20207:30 amRNSIssue of Equity
30th Jul 20205:23 pmRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
29th Jul 20207:00 amRNSResult of AGM
22nd Jul 20204:15 pmRNSIssue of Equity
22nd Jul 202012:10 pmRNSDirector/PDMR Shareholding
10th Jul 20202:07 pmRNSDirector/PDMR Shareholding
10th Jul 20202:06 pmRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSAuM Update
7th Jul 20208:03 amRNSHolding(s) in Company
6th Jul 202010:08 amRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
2nd Jul 20209:19 amRNSDirector/PDMR Shareholding
1st Jul 20202:10 pmRNSIssue of Equity
1st Jul 20207:00 amRNSTotal Voting Rights
29th Jun 202010:03 amRNSDirector/PDMR Shareholding
26th Jun 20201:10 pmRNSAnnual Financial Report
25th Jun 202010:26 amRNSHolding(s) in Company
25th Jun 202010:25 amRNSDirector/PDMR Shareholding
24th Jun 20203:29 pmRNSIssue of Equity
22nd Jun 20204:04 pmRNSDividend Declaration
22nd Jun 20207:00 amRNSGroup Audited Results for year ended 31 March 2020
18th Jun 202012:08 pmRNSSecond Price Monitoring Extn
18th Jun 202012:02 pmRNSPrice Monitoring Extension
5th Jun 202010:31 amRNSDirector/PDMR Shareholding
4th Jun 20207:16 amRNSNotice of Results
1st Jun 20207:00 amRNSTotal Voting Rights
19th May 20202:00 pmRNSIssue of Equity
12th May 202010:22 amRNSDirector/PDMR Shareholding
11th May 20201:15 pmRNSDirectorate Change
6th May 202011:36 amRNSHolding(s) in Company
4th May 20201:07 pmRNSIssue of Equity
4th May 202011:24 amRNSDirector/PDMR Shareholding
15th Apr 202012:00 pmRNSFund Termination
9th Apr 20204:26 pmRNSDirectorate Change
9th Apr 202012:02 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSAuM Update
7th Apr 20204:40 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSBoard Changes
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.